Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,479 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized Controlled Trial of Darbepoetin α Versus Continuous Erythropoietin Receptor Activator Injected Subcutaneously Once Every Four Weeks in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage.
Furukawa T, Okada K, Abe M, Tei R, Oikawa O, Maruyama N, Maruyama T. Furukawa T, et al. Among authors: maruyama t, maruyama n. Int J Mol Sci. 2015 Dec 18;16(12):30181-9. doi: 10.3390/ijms161226229. Int J Mol Sci. 2015. PMID: 26694377 Free PMC article. Clinical Trial.
Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial.
Takashima H, Yoshida Y, Nagura C, Furukawa T, Tei R, Maruyama T, Maruyama N, Abe M. Takashima H, et al. Among authors: maruyama t, maruyama n. Diab Vasc Dis Res. 2018 Sep;15(5):469-472. doi: 10.1177/1479164118782872. Epub 2018 Jun 20. Diab Vasc Dis Res. 2018. PMID: 29923427 Free article. Clinical Trial.
Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.
Abe M, Okada K, Maruyama N, Matsumoto S, Maruyama T, Fujita T, Matsumoto K, Soma M. Abe M, et al. Among authors: maruyama t, maruyama n. Expert Opin Investig Drugs. 2010 Sep;19(9):1027-37. doi: 10.1517/13543784.2010.505918. Expert Opin Investig Drugs. 2010. PMID: 20649501 Clinical Trial.
3,479 results